Non-sebaceous lymphadenoma of the submandibular gland: diagnostic challenges in the head and neck cancer pathway

2020 ◽  
Vol 13 (11) ◽  
pp. e238099
Author(s):  
Graham Garside ◽  
Dominic Jaikaransingh ◽  
Gayani Pitiyage ◽  
Enyinnaya Ofo

Non-sebaceous lymphadenoma (NSLA) is a rare benign salivary gland tumour with lymphoid and epithelial components and without sebaceous differentiation. The large majority of the reported cases arise within the parotid gland. We present an NSLA arising from the submandibular gland. The tumour presented as a painless longstanding neck lump. Ultrasound, fine needle aspiration, MRI and positron emission tomography found features supportive of squamous cell carcinoma. The patient was treated with surgery for oropharyngeal carcinoma of unknown origin, in accordance with local and national guidelines. The final histological assessment revealed the level Ib neck lesion to be NSLA. Although a rare occurrence, these lesions may pose a diagnostic challenge in the head and neck cancer pathway.

ORL ◽  
2015 ◽  
Vol 77 (2) ◽  
pp. 70-86 ◽  
Author(s):  
Fanglong Wu ◽  
Shengxin Weng ◽  
Chunjie Li ◽  
Jun Sun ◽  
Longjiang Li ◽  
...  

Oral Oncology ◽  
2010 ◽  
Vol 46 (5) ◽  
pp. 349-354 ◽  
Author(s):  
G.C. Jaguar ◽  
E.N.P. Lima ◽  
L.P. Kowalski ◽  
A.C. Pellizon ◽  
A.L. Carvalho ◽  
...  

2019 ◽  
Vol 44 (2) ◽  
pp. e110-e112
Author(s):  
Darko Pucar ◽  
Michael W. Groves ◽  
Paul Biddinger ◽  
Ramon Figueroa ◽  
Hadyn T. Williams

Head & Neck ◽  
2003 ◽  
Vol 25 (11) ◽  
pp. 889-894 ◽  
Author(s):  
Beno�t Mesurolle ◽  
Fran�ois Mignon ◽  
Philippe Meingan ◽  
Christian Domenge ◽  
Manuella Vasile ◽  
...  

2019 ◽  
Vol 26 (3) ◽  
pp. 580-586
Author(s):  
Alina T Jaeger ◽  
James E Connelly ◽  
Ruyun Jin ◽  
Samuel N Jacobson ◽  
Rom S Leidner

Background/objective National guidelines do not recommend the routine use of antimicrobial prophylaxis in patients with solid tumors, yet prophylactic agents are still sometimes prescribed for head and neck cancer patients. The purpose of this study is to determine the effect of prophylactic antimicrobials on the incidence of infection in patients undergoing chemoradiation for head and neck cancer. Methods Between 2013 and 2016, patients receiving chemoradiation for head and neck cancer at three outpatient oncology clinics were identified by retrospective review. Cohorts were based on administration or absence of prophylactic antimicrobials. The primary outcome of this study was incidence of infection. Secondary outcomes included incidence of hospitalization and length of hospital stay. Results Seventy-seven patients were analyzed, 47% (n = 36) were not prescribed antimicrobial prophylaxis and 53% (n = 41) were prescribed prophylaxis. Infection occurred in 31 patients in the no prophylaxis cohort and in 34 patients in the prophylaxis cohort (86.1% vs. 82.9%, p = 0.945). Twenty patients in the no prophylaxis cohort were hospitalized versus 16 patients in the prophylaxis cohort ( p = 0.222). The average length of hospital stay was 6 days in the no prophylaxis cohort and 10.6 days in the prophylaxis cohort ( p = 0.007). Conclusion The use of antimicrobial prophylaxis did not significantly impact the incidence of infection when compared to patients who were not prescribed prophylaxis. There was no difference in the incidence of hospitalization, however, the patients in the prescribed prophylactic group had longer length of hospital stay.


Sign in / Sign up

Export Citation Format

Share Document